Transcept Pharmaceuticals Inc
Transcept Pharmaceuticals Inc (TSPT) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 131 transactions totaling $15.0M, demonstrating a bullish sentiment with $1.9M in net insider flow. The most recent transaction on Oct 30, 2014 involved a transaction of 10,613 shares valued at $229.1K.
TSPT Insider Activity Summary
Who Is Buying TSPT Stock?
No significant insider buying has been recorded for TSPT in the recent period.
Who Is Selling TSPT Stock?
No significant insider selling has been recorded for TSPT in the recent period.
Is Transcept Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TSPT is bullish with an Insider Alignment Score of 56/100 and a net flow of $1.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TSPT Frequently Asked Questions
Understanding TSPT Insider Activity
Insider trading at Transcept Pharmaceuticals Inc (TSPT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading TSPT stock, having executed 131 transactions in the past 90 days. The most active insider is Christopher B. Ehrlich (Executive), who has made 3 transactions totaling $5.0M.
Related Tools
Track Transcept Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at TSPT file new Form 4 transactions